CRINETICS PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, April 12, 2018, a trademark application was filed for CRINETICS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the CRINETICS PHARMACEUTICALS trademark a serial number of 87875067. The federal status of this trademark filing is REGISTERED as of Tuesday, December 28, 2021. This trademark is owned by Crinetics Pharmaceuticals, Inc.. The CRINETICS PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, co...
crinetics pharmaceuticals

General Information

Serial Number87875067
Word MarkCRINETICS PHARMACEUTICALS
Filing DateThursday, April 12, 2018
Status700 - REGISTERED
Status DateTuesday, December 28, 2021
Registration Number6603347
Registration DateTuesday, December 28, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements

Description of MarkThe mark consists of the word "CRINETICS" above the word "PHARMACEUTICALS" with a dot and line spirograph design in the shape of a half circle starting above the letter "I" in "CRINETICS" and wrapping around the first letter "C" in "CRINETICS".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 21, 2018
Primary Code042
First Use Anywhere DateWednesday, May 12, 2021
First Use In Commerce DateWednesday, May 12, 2021

Trademark Owner History

Party NameCrinetics Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameCrinetics Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameCrinetics Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Wednesday, February 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 28, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 28, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 28, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, November 20, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 19, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 2, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, October 29, 2021USE AMENDMENT FILED
Friday, October 29, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, May 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 7, 2021SOU EXTENSION 5 GRANTED
Thursday, April 29, 2021SOU EXTENSION 5 FILED
Friday, May 7, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 29, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020SOU EXTENSION 4 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 4 FILED
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2020SOU EXTENSION 3 GRANTED
Friday, April 24, 2020SOU EXTENSION 3 FILED
Friday, April 24, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2019SOU EXTENSION 2 GRANTED
Monday, October 21, 2019SOU EXTENSION 2 FILED
Monday, October 21, 2019SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2019SOU EXTENSION 1 GRANTED
Wednesday, April 17, 2019SOU EXTENSION 1 FILED
Wednesday, April 17, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, April 17, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 17, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 16, 2018ASSIGNED TO LIE
Monday, August 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 6, 2018EXAMINER'S AMENDMENT ENTERED
Monday, August 6, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 6, 2018EXAMINERS AMENDMENT E-MAILED
Monday, August 6, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Tuesday, April 24, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, April 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 16, 2018NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals crinetics research medical pharmaceutical field receptors treating disorders system scientific endocrine